TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1

EMBO Journal

Volumn 20, Issue 20, 2001, Pages 5678-5691

  Schultheiss, Ute ^a   Püschner, Stephanie ^b   Kremmer, Elisabeth ^c   Mak, Tak W ^d   Engelmann, Hartmut ^b   Hammerschmidt, Wolfgang ^a   Kieser, Arnd ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d AMGEN INSTITUTE   (Canada)

Author keywords

LMP1; p38 MAPK; Signal transduction; TRADD; TRAF6

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FIBROBLAST; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VIRUS ONCOGENE;

AMINO ACID MOTIFS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL LINE; CELL TRANSFORMATION, VIRAL; ENZYME INDUCTION; FIBROBLASTS; GENE TARGETING; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MACROMOLECULAR SUBSTANCES; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TYROSINE;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0035887040     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.20.5678     Document Type: Article

References (69)

1. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells
2. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
3. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue
4. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus
5. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
6. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs
7. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes
8. Epstein-Barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-κB
9. TRAF6 is a signal transducer for interleukin-1
10. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes
11. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation
12. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein l-induced cell gene expression
13. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2
14. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production
15. Epstein-Barr virus immortalizing genes
16. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein
17. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-teminus and requires oligomerisation for NF-κB activation
18. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions
19. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
20. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
21. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
22. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor α gene expression in T lymphocytes
23. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
24. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
25. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
26. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
27. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation
28. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation
29. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-κB activation
30. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
31. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues
32. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
33. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex
34. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells
35. Epstein-Barr virus and its replication
36. Assaying the activity of kinases regulated by LMP1
37. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
38. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2
39. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
40. Calcium phosphate transfection
41. Epstein-Barr virus strategy in normal and neoplastic B cells
42. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
43. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κ B
44. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
45. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes
46. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
47. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
48. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
49. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
50. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts
51. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
52. p38 MAP kinases: Beyond the stress response
53. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway
54. The p38 signal transduction pathway: Activation and function
55. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization
56. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs
57. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
58. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells
59. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3
60. Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1
61. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
62. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ
63. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses
64. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway
65. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
66. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression
67. The structural basis for the recognition of diverse receptor sequences by TRAF2
68. Transducing signals of life and death
69. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival